Parag Kumar
Impact in
- Infectious Diseases top 10%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
-
- Adrenal Hormones and Disorders
- Hormonal Regulation and Hypertension
Papers in
-
- HIV/AIDS drug development and treatment 6
- Antifungal resistance and susceptibility 3
-
- Sexual Differentiation and Disorders 4
- Co-authors
- Kristina M. Brooks (11 shared papers)Ashwini Mallappa (4 shared papers)Deborah P. Merke (4 shared papers)Ninet Sinaii (3 shared papers)Kevin Laliberte (3 shared papers)Robert Evers (1 shared paper)Daniel S. Reich (1 shared paper)Jomy George (6 shared papers)
- Journals
- The Journal of Clinical Pharmacology (5 papers)Clinical Pharmacology & Therapeutics (3 papers)The Journal of Clinical Endocrinology & Metabolism (2 papers)Journal of Clinical Oncology (2 papers)Open Forum Infectious Diseases (2 papers)
- Partner nations
- United StatesHungaryThailand
In The Last Decade
Parag Kumar
43 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 113
- Infectious Diseases 220
- Endocrinology, Diabetes and Metabolism 178
- Immunology 193
- Biomaterials 109
- Behavioral Neuroscience 18
Countries citing papers authored by Parag Kumar
This map shows the geographic impact of Parag Kumar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Parag Kumar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Parag Kumar more than expected).
Fields of papers citing papers by Parag Kumar
This network shows the impact of papers produced by Parag Kumar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Parag Kumar. The network helps show where Parag Kumar may publish in the future.
Co-authors
The 25 scholars most cited alongside Parag Kumar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 132 | |
| 2 | 2014 | 122 | |
| 3 | 2018 | 93 | |
| 4 | 2016 | 89 | |
| 5 | 2017 | 84 | |
| 6 | 2016 | 65 | |
| 7 | 2013 | 63 | |
| 8 | 2012 | 58 | |
| 9 | 2016 | 54 | |
| 10 | 2014 | 49 | |
| 11 | 2017 | 49 | |
| 12 | 2018 | 47 | |
| 13 | 2017 | 44 | |
| 14 | 2018 | 31 | |
| 15 | 2015 | 26 | |
| 16 | 2015 | 25 | |
| 17 | 2017 | 20 | |
| 18 | 2016 | 20 | |
| 19 | 2017 | 19 | |
| 20 | 2013 | 17 |
About Parag Kumar
Parag Kumar is a scholar working on Infectious Diseases, Molecular Biology, Oncology, Immunology and Biomaterials, having authored 45 papers that have together received 1.3k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (6 papers), HIV/AIDS drug development and treatment (6 papers), Sexual Differentiation and Disorders (4 papers), Complementary and Alternative Medicine Studies (3 papers), Antifungal resistance and susceptibility (3 papers), Drug Transport and Resistance Mechanisms (3 papers), Pulmonary Hypertension Research and Treatments (3 papers) and Pharmacological Effects of Natural Compounds (3 papers). The work is most often cited by research in Infectious Diseases (220 citations), Endocrinology, Diabetes and Metabolism (178 citations), Immunology (193 citations), Biomaterials (109 citations) and Behavioral Neuroscience (18 citations). Parag Kumar has collaborated with scholars based in United States, Hungary and Thailand. Frequent co-authors include Kristina M. Brooks, Ashwini Mallappa, Deborah P. Merke, Ninet Sinaii, Kevin Laliberte, Robert Evers, Daniel S. Reich, Jomy George, Ashkan A. Malayeri and David A. Bluemke. Their work appears in journals such as The Journal of Clinical Pharmacology, Clinical Pharmacology & Therapeutics, The Journal of Clinical Endocrinology & Metabolism, Journal of Clinical Oncology and Open Forum Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.